These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 14998498)

  • 1. Directly observed therapy for HIV/tuberculosis co-infection.
    Lurie MN; Carter EJ; Cohen J; Flanigan TP
    Lancet Infect Dis; 2004 Mar; 4(3):137-8. PubMed ID: 14998498
    [No Abstract]   [Full Text] [Related]  

  • 2. Lack of appropriate treatment for people with comorbid HIV/AIDS and epilepsy in sub-Saharan Africa.
    Birbeck G; Chomba E; Ddumba E; Kauye F; Mielke J
    Epilepsia; 2007 Jul; 48(7):1424-5. PubMed ID: 17635568
    [No Abstract]   [Full Text] [Related]  

  • 3. Time to rethink guidelines for tuberculosis treatment initiation in HIV-infected patients in developing countries.
    Tattevin P
    Int J Tuberc Lung Dis; 2011 Mar; 15(3):423-4. PubMed ID: 21333119
    [No Abstract]   [Full Text] [Related]  

  • 4. Managing HIV and tuberculosis in sub-Saharan Africa.
    Harries AD; Boxshall M; Phiri S; Kwanjana J
    Lancet; 2006 Jun; 367(9525):1817-8. PubMed ID: 16753481
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment. Individual approach needed for co-infections.
    AIDS Policy Law; 2011 Dec; 27(1):1. PubMed ID: 22319816
    [No Abstract]   [Full Text] [Related]  

  • 6. Antiretroviral drugs for tuberculosis control in the era of HIV/AIDS.
    Williams BG; Dye C
    Science; 2003 Sep; 301(5639):1535-7. PubMed ID: 12920302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TB and HIV: joint problems, joint solutions?
    Elzinga G; Nunn P
    Bull World Health Organ; 2002; 80(6):469-70. PubMed ID: 12132004
    [No Abstract]   [Full Text] [Related]  

  • 8. Tuberculosis of the pancreas mimicking carcinoma.
    Eyal AS; Karusseit VO
    Int J Infect Dis; 2008 Jan; 12(1):108-10. PubMed ID: 17587622
    [No Abstract]   [Full Text] [Related]  

  • 9. A clinical and epidemiologic update on the interaction between tuberculosis and human immunodeficiency virus infection in adults.
    Habib AG
    Ann Afr Med; 2009; 8(3):147-55. PubMed ID: 19884690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The SAPIT trial provides essential evidence on risks and benefits of integrated and sequential treatment of HIV and tuberculosis.
    Abdool Karim Q; Abdool Karim SS; Baxter C; Friedland G; Gengiah T; Gray A; Grobler A; Naidoo K; Padayatchi N; El-Sadr W
    S Afr Med J; 2010 Dec; 100(12):808-9. PubMed ID: 21414268
    [No Abstract]   [Full Text] [Related]  

  • 11. Highly active antiretroviral therapy (HAART) in adults with tuberculosis: current status.
    Kwara A; Flanigan TP; Carter EJ
    Int J Tuberc Lung Dis; 2005 Mar; 9(3):248-57. PubMed ID: 15786886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From directly observed therapy to accompagnateurs: enhancing AIDS treatment outcomes in Haiti and in Boston.
    Behforouz HL; Farmer PE; Mukherjee JS
    Clin Infect Dis; 2004 Jun; 38 Suppl 5():S429-36. PubMed ID: 15156434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of tuberculosis directly observed therapy programs as sites for access to and provision of antiretroviral therapy in resource-limited countries.
    Friedland G; Abdool Karim S; Abdool Karim Q; Lalloo U; Jack C; Gandhi N; El Sadr W
    Clin Infect Dis; 2004 Jun; 38 Suppl 5():S421-8. PubMed ID: 15156433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV/AIDS: the private sector is vital.
    England R
    Lancet; 2004 Sep 18-24; 364(9439):1033-4. PubMed ID: 15380956
    [No Abstract]   [Full Text] [Related]  

  • 15. Finding patients eligible for antiretroviral therapy using TB services as entry point for HIV treatment.
    Bwire R; Nagelkerke NJ; Borgdorff MW
    Trop Med Int Health; 2006 Oct; 11(10):1567-75. PubMed ID: 17002731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment outcomes of patients co-infected with HIV and tuberculosis who received a nevirapine-based antiretroviral regimen: a four-year prospective study.
    Manosuthi W; Tantanathip P; Chimsuntorn S; Eampokarap B; Thongyen S; Nilkamhang S; Sungkanuparph S
    Int J Infect Dis; 2010 Nov; 14(11):e1013-7. PubMed ID: 20880733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delivery of antiretroviral therapy in sub-saharan Africa.
    Weller I
    Clin Infect Dis; 2006 Sep; 43(6):777-8. PubMed ID: 16912955
    [No Abstract]   [Full Text] [Related]  

  • 18. DOT or SAT for Rifampicin-resistant tuberculosis? A non-randomized comparison in a high HIV-prevalence setting.
    Mohr E; Daniels J; Beko B; Isaakidis P; Cox V; Steele SJ; Muller O; Snyman L; De Azevedo V; Shroufi A; Trivino Duran L; Hughes J
    PLoS One; 2017; 12(5):e0178054. PubMed ID: 28542441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tuberculosis and the human immunodeficiency virus: unholy marriage of the millennium.
    Chakaya JM
    East Afr Med J; 2008 Nov; 85(11):521-2. PubMed ID: 19413203
    [No Abstract]   [Full Text] [Related]  

  • 20. Predicting the failure of 3 by 5.
    Brown RC; Brown JE
    Lancet; 2005 Jul 9-15; 366(9480):117-8. PubMed ID: 16005323
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.